Flakka is a common name for a synthetic psychoactive substance belonging to the group of synthetic cathinones. In media coverage, it is sometimes described as a “zombie drug” because of the extreme behaviour observed in some users. This term is not a medical diagnosis, but it does reflect how intense the psychiatric and physical symptoms associated with this substance can be.

What flakka is

Flakka is a street name for the chemical compound alpha-PVP, a synthetic stimulant that acts on the central nervous system. The substance may be taken orally, intranasally, intravenously, or by inhalation. Its effects are linked to strong stimulation of dopaminergic and noradrenergic pathways, which can lead to a sharp increase in psychomotor agitation.

Unlike substances with a more predictable composition, synthetic cathinones often appear in changing chemical variants. This makes their effects harder to predict and increases the risk of serious complications.

Why flakka is called the “zombie drug”

In some people, flakka use has been associated with extreme agitation, aggression, disorientation, and impulsive behaviour. Media reports often focus on cases involving loss of control, severe hallucinations, and reactions that are clearly disproportionate to external stimuli.

From a clinical perspective, these symptoms may reflect severe toxic psychosis together with intense overstimulation of the nervous system. High doses or the use of flakka together with other substances significantly increase the risk of serious medical complications.

Symptoms associated with flakka use

The most commonly described symptoms include:

• severe psychomotor agitation
• aggression and loss of behavioural control
• hallucinations and delusions
• high body temperature
• cardiac rhythm disturbances
• sudden rise in blood pressure

This condition may lead to serious neurological and cardiovascular complications, including life-threatening outcomes.

Risks and complications

Flakka is associated with a high risk of acute psychosis, rhabdomyolysis, metabolic disturbance, and severe cardiovascular complications. An additional danger comes from the unpredictability of dose and purity.

People with a history of mental health disorders, especially psychosis or severe depression, are at increased risk of destabilisation after using this substance.

How to protect yourself

The most effective way to reduce risk is to avoid using substances with unknown composition and unknown effects. The danger is especially high when flakka is combined with alcohol, sedatives, or other drugs. Mixing substances significantly increases the risk of poisoning and acute psychiatric or medical crisis.

In environments where synthetic cathinones may be present, education and rapid recognition of symptoms of severe agitation are important protective measures.

When medical help is necessary

Urgent medical help is necessary in cases of severe aggression, loss of consciousness, seizures, very high body temperature, breathing difficulty, or marked cardiac rhythm disturbance. These are emergencies that require immediate intervention.

When flakka or other synthetic stimulants have been used, medical stabilisation may be necessary. This stage of care is described on the page drug detox.

Treatment of addiction to synthetic stimulants

Regular use of flakka may lead to psychological dependence and recurrent episodes of psychosis. Treatment includes stabilisation of mental state and therapy focused on the mechanisms that maintain substance use. The treatment model for stimulant-related addiction is described on the page stimulant addiction treatment.

The therapeutic process requires individual medical qualification and monitoring, especially when co-occurring mental health disorders are present.